University of Minnesota
Minneapolis, Minnesota, 55454, United States
NCT Number: NCT04562688
This is a validation study to evaluate the acceptability, feasibility and impact of CICADAS (Care Improving Cognition for ADolescents on the Autism Spectrum), a clinician-assisted, digital application that aims to prime the brain to engage in flexible, adaptive long-term learning about social-emotional events through closed-loop technology.
Looking for future studies?
Notify Me11 year–18 year
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55454, United States
This study will employ an innovative and evidence-based digital intervention that includes ten digital assessments (CICADAS app) that will capture data on sensory processing abnormalities and associated cognitive deficits. We will leverage pilot data collected in adolescents with Autism Spectrum Disorder (ASD) and accumulate preliminary evidence for CICADAS app to function as 1) a stand-alone treatment; 2) a primer for PEERS (Program for the Education and Enrichment of Relationship Skills); 3) an enhancer for PEERS. This study will test CICADAS app in adolescents with ASD in a three-arm, active-controlled randomized crossover trial to document the acceptability and evaluate its potential as a stand-alone treatment, as a primer for PEERS, or as a treatment enhancer of PEERS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants completed baseline assessments and neuroplasticity-based targeted cognitive training (NB-TCT) exercises on a digital device for up to 40 hours through BrainHQ (Posit Science Corporation, San Francisco). The CICADAS app captures user-specific sensory and cognitive processing metrics through 10 brief computerized assessments; these data are used to guide and personalize the delivery of 13 NB-TCT exercises. The NB-TCT exercises are adaptive with the task difficulty adjusting on a trial-to-trial and session-by-session basis to the abilities of each individual. A second set of computerized assessments was administered following the intervention period. Participants had to log in to access these assessments and exercises using a study provided username that contained no personally identifiable information.
Participants will complete both PEERS and CICADAS study activities. Participants completed baseline assessments and neuroplasticity-based targeted cognitive training (NB-TCT) exercises on a digital device for up to 40 hours through BrainHQ (Posit Science Corporation, San Francisco). The CICADAS app captures user-specific sensory and cognitive processing metrics through 10 brief computerized assessments; these data are used to guide and personalize the delivery of 13 NB-TCT exercises. In addition, participants will be asked to attend weekly 1-hour group sessions led by a PEERS clinician. Each PEERS group session will consist of a minimum of 3 participants and will meet as a group using Zoom. PEERS teaches how to solve real-life social dilemmas, appraise affect and social contexts, and initiate and maintain conversations while receiving feedback from peers and clinicians. After 16 weeks, participant will crossover to No-Contact with no active intervention.
Participants will complete both PEERS and Active Comparator study activities. Participants will engage in computerized, casual video games for a total of 40 hours. Participants will also complete the 10 sensory processing abnormalities (SPA) computerized assessments. In addition, participants will be asked to attend weekly 1-hour group sessions led by a PEERS clinician. Each PEERS group session will consist of a minimum of 3 participants and will meet as a group using Zoom. PEERS teaches how to solve real-life social dilemmas, appraise affect and social contexts, and initiate and maintain conversations while receiving feedback from peers and clinicians. After 16 weeks, participant will crossover to No-Contact with no active intervention.
Time frame: 16 weeks
The total number participants who completed the training-based assessments were evaluated. All were participants were administered the assessments before and after the intervention period. The training-based assessments include 12 computerized tasks focused on attention, memory and social cognition.
Time frame: 16 weeks
The mean number of program sessions completed were evaluated.
Time frame: 16 weeks
The reported number of adverse events due to program use were evaluated.
Time frame: 16 weeks
The total number of participants who completed the Post-Intervention assessments were evaluated.
Time frame: 32 weeks
The total number of participants who completed the follow-up assessments were evaluated.
Time frame: Baseline, 16 weeks and 32 weeks
Measures breadth of repetitive behavior with subscales: Stereotyped Behavior, Self-injurious Behavior, Compulsive Behavior, Routine Behavior, Sameness Behavior, and Restricted Behavior. Scoring range: 0-129; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures severity of autism spectrum symptoms as they occur in natural social settings. Scoring Range: 0-174; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-24; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-36; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-48; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-30; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-36; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measure of behavioral and emotional functioning; Composite scales: Internalizing Problems sums Anxious/depressed, Withdrawn-depressed, and Somatic complaints scores; Externalizing Problems combines Rule-breaking and Aggressive behavior; Total Problems sums scores of all problem items. Scoring Range: 0-134; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-64; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-70; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Assesses impairments in executive function across Global Executive Composite, Behavior Regulation, Emotional Recognition, and Cognitive Regulation Indices. Scoring Range: 60-180; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 12-36; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 32-96; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 16-48; Lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Neuropsychological test of set-shifting, the capability to show flexibility when exposed to changes in reinforcement. Lower score is better.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-100%; lower score is better.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-100%; lower score is better.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-100%; lower score is better.
Time frame: Baseline, 16 weeks and 32 weeks
Test of selective attention and inhibitory control, in which participants are asked to indicate the target letter while ignoring an array of "flanking" congruent/incongruent letters. Scoring Range: 0-100%, higher score is better.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring Range: 0-100%; higher score is better.
Time frame: Baseline, 16 weeks and 32 weeks
The accuracy interference score is calculated by subtracting the mean accuracy for the congruent items from the mean accuracy for the incongruent items. Lower score indicates better performance, reflecting less difficulty inhibiting responses to incongruent stimuli. Baseline Score Range: Min -27.27, Max 28.76; At 16 Weeks Score Range: Min -23.50, Max 16.38; At 32 Weeks Score Range: Min -30.00, Max 30.91
Time frame: Baseline, 16 weeks and 32 weeks
The reaction time interference score was calculated by subtracting the mean reaction time for the correct congruent items from the mean reaction time for the correct incongruent items. Lower score indicates better performance, reflecting less difficulty inhibiting responses to incongruent stimuli.
Time frame: Baseline, 16 weeks and 32 weeks
Measures health-related quality of life. Scoring range: 0-100; higher score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring range: 0-100; higher score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Scoring range: 0-100; higher score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-12; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-36; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-20; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-16; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-12; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-24; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-40; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Measures sensory vulnerabilities of auditory processing, visual processing, tactile processing, and eating and feeding behaviors. Scoring Range: 0-40; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Screening for auditory processing difficulties; Subtests: Competing Words (dichotic listening tasks) and Filtered Words (speech processing when the signal is distorted or compromised by a poor acoustic environment). Scoring Range: 0-60; higher score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Screening for auditory processing difficulties; Subtests: Competing Words (dichotic listening tasks) and Filtered Words (speech processing when the signal is distorted or compromised by a poor acoustic environment). Scoring Range: 0-40; higher score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Assesses social skills, problem behaviors, and academic competence. Scoring Range: 0-138; higher score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Assesses social skills, problem behaviors, and academic competence. Scoring Range: 0-45; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Assesses social skills, problem behaviors, and academic competence. Scoring Range: 0-99; lower score means a better outcome.
Time frame: Baseline, 16 weeks and 32 weeks
Assesses treatment changes in adolescents' knowledge of social skills taught during PEERS. Scoring Range: 0-30; higher score means a better outcome.
Posit Science Corporation
Industry
Care Improving Cognition for ADolescents on the Autism Spectrum (CICADAS)
Acronym: CICADAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT07277101
Autism Spectrum Disorder, Autistic Disorder
Shanghai, China
View Trial DetailsNCT06361147
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Heraklion, Crete, Greece
View Trial DetailsNCT06508515
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Seattle, Washington, United States
View Trial Details